These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28699320)

  • 1. A three plus three parameters mechanistic model for viral filtration.
    Misra P; Sinha A; Rathore AS; Shukla A; Mir FQ
    Biotechnol Prog; 2017 Nov; 33(6):1538-1547. PubMed ID: 28699320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus.
    Roush DJ; Myrold A; Burnham MS; And JV; Hughes JV
    Biotechnol Prog; 2015; 31(1):135-44. PubMed ID: 25395156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic failure mode investigation and resolution of parvovirus retentive filters.
    LaCasse D; Lute S; Fiadeiro M; Basha J; Stork M; Brorson K; Godavarti R; Gallo C
    Biotechnol Prog; 2016 Jul; 32(4):959-70. PubMed ID: 27160325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus filtration of high-concentration monoclonal antibody solutions.
    Marques BF; Roush DJ; Göklen KE
    Biotechnol Prog; 2009; 25(2):483-91. PubMed ID: 19353736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving a Successful Scale-Down Model and Optimized Economics through Parvovirus Filter Validation using Purified TrueSpikeTM Viruses.
    De Vilmorin P; Slocum A; Jaber T; Schaefer O; Ruppach H; Genest P
    PDA J Pharm Sci Technol; 2015; 69(3):440-9. PubMed ID: 26048749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of viral filtration performance of monoclonal antibodies based on biophysical properties of feed.
    Rayfield WJ; Roush DJ; Chmielowski RA; Tugcu N; Barakat S; Cheung JK
    Biotechnol Prog; 2015; 31(3):765-74. PubMed ID: 25919945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of virus retention by size exclusion membranes under different flow regimes.
    Kosiol P; Kahrs C; Thom V; Ulbricht M; Hansmann B
    Biotechnol Prog; 2019 Mar; 35(2):e2747. PubMed ID: 30431234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of membrane structure on the filtrate flux during monoclonal antibody filtration through virus retentive membranes.
    Billups M; Minervini M; Holstein M; Feroz H; Ranjan S; Hung J; Bao H; Li ZJ; Ghose S; Zydney AL
    Biotechnol Prog; 2022 Mar; 38(2):e3231. PubMed ID: 34994527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a 20-nm pore-size filter in the plasma-derived factor VIII manufacturing process.
    Furuya K; Murai K; Yokoyama T; Maeno H; Takeda Y; Murozuka T; Wakisaka A; Tanifuji M; Tomono T
    Vox Sang; 2006 Aug; 91(2):119-25. PubMed ID: 16907872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Effect of the Volume Throughput and Maximum Flux of Low-Surface-Tension Fluids on Bacterial Penetration of 0.2 Micron-Rated Filters during Process-Specific Filter Validation Testing.
    Folmsbee M
    PDA J Pharm Sci Technol; 2015; 69(2):307-16. PubMed ID: 25868996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial, viral and turbidity removal by intermittent slow sand filtration for household use in developing countries: experimental investigation and modeling.
    Jenkins MW; Tiwari SK; Darby J
    Water Res; 2011 Nov; 45(18):6227-39. PubMed ID: 21974872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A size-exclusion nanocellulose filter paper for virus removal.
    Metreveli G; Wågberg L; Emmoth E; Belák S; Strømme M; Mihranyan A
    Adv Healthc Mater; 2014 Oct; 3(10):1546-50, 1524. PubMed ID: 24687994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adapting virus filtration to enable intensified and continuous monoclonal antibody processing.
    Bohonak DM; Mehta U; Weiss ER; Voyta G
    Biotechnol Prog; 2021 Mar; 37(2):e3088. PubMed ID: 33016523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scale-up of Sterilizing-grade Membrane Filters from Discs to Pleated Cartridges: Effects of Operating Parameters and Solution Properties.
    Kumar A; Martin J; Kuriyel R
    PDA J Pharm Sci Technol; 2015; 69(1):74-87. PubMed ID: 25691716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microscopic visualization of virus removal by dedicated filters used in biopharmaceutical processing: Impact of membrane structure and localization of captured virus particles.
    Adan-Kubo J; Tsujikawa M; Takahashi K; Hongo-Hirasaki T; Sakai K
    Biotechnol Prog; 2019 Nov; 35(6):e2875. PubMed ID: 31228338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for Tailoring the Pore-Size Distribution of Virus Retention Filter Papers.
    Gustafsson S; Mihranyan A
    ACS Appl Mater Interfaces; 2016 Jun; 8(22):13759-67. PubMed ID: 27144657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A consensus rating method for small virus-retentive filters. I. Method development.
    Lute S; Riordan W; Pease LF; Tsai DH; Levy R; Haque M; Martin J; Moroe I; Sato T; Morgan M; Krishnan M; Campbell J; Genest P; Dolan S; Tarrach K; Meyer A; ; Zachariah MR; Tarlov MJ; EtzeL M; Brorson K; Aranha H; Bailey M; Bender J; Carter J; Chen Q; Dowd C; Jani R; Jen D; Kidd S; Meltzer T; Remington K; Rice I; Romero C; Sato T; Jornitz M; Sekura CM; Sofer G; Specht R; Wojciechowski P;
    PDA J Pharm Sci Technol; 2008; 62(5):318-33. PubMed ID: 19055228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pH, NaCl concentration, and mAb concentration of feed solution on the filterability of Planova™ 20N and Planova™ BioEX.
    Hashikawa-Muto C; Yokoyama Y; Hamamoto R; Kobayashi K; Masuda Y; Nonaka K
    Biotechnol Prog; 2024; 40(2):e3420. PubMed ID: 38146091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus filter scalability: Demonstration of consistent viral clearance across laboratory and manufacturing scales.
    Buesing B; Schwartz A; Shah A; Sohka T; Hirotomi N; Strauss D
    Biologicals; 2021 Jul; 72():27-32. PubMed ID: 34226123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.